Number of Shares
423,632.00
Current Holdings Value*
$4.69 Mil
% of Portfolio
5.57%
Total Estimate Gain
$1.09 Mil
% of Total Estimate Gain
12.47%

SUPERSTRING CAPITAL MANAGEMENT LP's UroGen Pharma Ltd Holding Summary

As of 2025-03-31, SUPERSTRING CAPITAL MANAGEMENT LP held 423,632.00 shares of UroGen Pharma Ltd(URGN), totaling $4.69 Mil. This investment constitutes 5.57% of their stock portfolio, and SUPERSTRING CAPITAL MANAGEMENT LP now holds 0.92% of the outstanding UroGen Pharma Ltd(URGN) stock.

The initial trade took place in 2023Q4. And since then SUPERSTRING CAPITAL MANAGEMENT LP has made 3 purchases of URGN, at an average price of $12.30, for a total of 711,899.00 shares. In addition, there have been 1 sales at an average price of $14.22 for 288,267.00 shares. Based on historical transaction data and URGN's current price of $13.58, SUPERSTRING CAPITAL MANAGEMENT LP's estimated gain on his URGN holdings is $1.09 Mil, reflecting a 12.47% gain to date.

SUPERSTRING CAPITAL MANAGEMENT LP URGN ($13.58) Holding Chart

SUPERSTRING CAPITAL MANAGEMENT LP URGN ($13.58) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1